MET Gene Amplification Is a Mechanism of Resistance to Entrectinib in ROS1+ NSCLC

Utilizing a primary, patient-derived TPM3-ROS1 cell line, the authors derived an entrectinib-resistant line and evaluated proliferation and signaling responses to tyrosine kinase inhibitors.